🌟2025 Femtech Stars Asia: Meet the Honourees

Words by Stephanie Thng, Head of Communications, FemTech Association Asia

In Conversation with the 2025 FemTech Stars Asia Honourees:

• Dr Petty Chen, CEO and co-founder of Milkiway

• Dr Foong Tsin Uin, Director & Chief Medical Officer, Osler Health

• Dr Tashiya Mirando, Medical Doctor, Osler Health

• Theresa Lovelin, Co-Founder of Magnolia Collective Wellness

Note: Honouree Sastya Wardani, Co-Founder of Ovy Health not featured, but also celebrated for her contributions to femtech & women's health.

The Honourees of the 2025 Femtech Stars Asia represent a new generation of women’s health leaders who are reimagining care models by combining medical rigour, technology, and a deep understanding of women’s lived experiences. In an interview with FemTech Association Asia, they reflect on their most meaningful milestones in 2025, their vision for transforming women’s health and the trends shaping the region’s femtech landscape in the year ahead.

A Year Defined by Clinical Innovations and Meaningful Systemic Change

Dr Petty Chen’s vision for the future of women’s health is grounded in a simple, compelling principle: healthy women build healthy families, and healthy families drive healthier communities.

For her, 2025 was defined by a milestone that brought together her clinical background, her focus on preventative care, and her drive to build scalable digital health solutions, namely Milkiway’s partnership with KK Women’s and Children’s Hospital to pilot computer-vision-enabled scoliosis screening. This solution shapes how doctors deliver care, helping children stand straighter and avoiding years of chronic back pain, nerve issues, heart and lung problems caused by rib cage compression. “This is exactly why I left clinical medicine to build technology,” she noted. “To enhance clinical outcomes while making the work of doctors and nurses easier.”

For Dr Tashiya Mirando, the launch of Singapore’s inaugural Menopause Summit in 2025 by the team at Osler Health, marked a pivotal shift in moving the conversation on women’s health forward, transforming menopause from a taboo topic to the mainstream. “My vision is to champion a future where women’s hormonal health across the ages are not silent transitions, but chapters of empowerment,” noted Dr Mirando.

Sharing a similar view, Theresa Lovelin’s vision is to revolutionise midlife women’s health. “We empower every woman with comprehensive, nurse-led, evidence-based care. This actively closes the systemic gaps that have left perimenopause and menopause underdiagnosed and misunderstood.” Reflecting on the past year, Theresa is most proud of how Magnolia Collective Wellness’ holistic, nurse-led care model rapidly moved from concept to real-world impact, supporting women across multiple countries.

Dr Foong Tsin Uin echoed this viewpoint from a complementary perspective,emphasising the role of technology and science in providing high quality healthcare to women. “My vision is to combine technology and a humanistic approach to empower women with the knowledge and courage to optimise their health span, to enable them to continue to thrive and be the best versions of themselves.” She added, “This has come together over the last year with the rapid progress globally in the areas of women’s health and longevity, underpinned by Osler’s solid foundational approach in advanced, progressive primary care, to enable us to make sense of the multitude of longevity tests and tech offerings.”

The 2026 Horizon – What Lies Ahead

Looking to the coming year, Dr Chen is energised by a growing shift in the women’s health and FemTech sectors: a move from viewing women as individual patients to recognising them as central influencers of family health behaviours.

Dr. Chen noted, “I am excited about the shift toward longitudinal, family-centered models that identify chronic disease risks early. The data is clear: mothers/ health behaviours directly influence the patterns their children form. [1] When only 53% of mothers achieve even 30 minutes of moderate activity once a week, the impact cascades through generations.”

For Dr Foong, the rapid advancement in precision medicine is noteworthy. “With technology, we are able to synthesize large volumes of data points needed to have a more personalised approach.” She added that the cross-over between the health and wellness sectors will contribute meaningfully to personalised preventive care, optimising the good years during a healthy life span, and ultimately reducing the burden on sick care leave.

In a similar vein, the convergence of personalised data, AI-driven insights, and holistic care models, excites Dr Mirando. She opined, “The move towards truly individualised health, where technology like predictive diagnostics meets personalised lifestyle and hormonal guidance, will revolutionise proactive wellness.” She added that the growing synergy between clinical health and the wellness industry promises to make preventive, sustainable care more accessible and engaging, ultimately optimising health span for women across Asia.

While women’s health has historically been underfunded and under-researched, Theresa is optimistic that 2026 will potentially be a pivotal year for intensified calls to action, accelerated research and increased femtech funding. She added, “The shift from mere awareness to accountability, positioning perimenopause as a public health, workforce and economic priority, is crucial. She believes that leveraging data, digital platforms, AI and wearables enables highly tailored interventions that respect biological and cultural nuances, while also enabling companies like Magnolia Wellness to deliver scalable, impactful solutions that can transform women’s health.

Source:  [1] Hesketh KR, Goodfellow L, Ekelund U, et al. Activity Levels in Mothers and Their

Preschool Children. Pediatrics. 2014;133(4):e973-e980. doi:10.1542/peds.2013-3153